Last updated: October 1, 2018
Sponsor: Yaron S. Rabinowitz M.D.
Overall Status: Active - Enrolling
Phase
2/3
Condition
Vision Loss
Eye Disease
Treatment
N/AClinical Study ID
NCT01081561
#20090780
Ages 21-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- progressive keratoconus or ectasia
Exclusion
Exclusion Criteria:
cornea thinner than 400um
K readings greater than 60D
Central corneal scarring
Study Design
Total Participants: 600
Study Start date:
January 21, 2009
Estimated Completion Date:
June 30, 2021
Study Description
Connect with a study center
Cornea Eye Institute, 50 North La Cienaga Blvd, #340
Beverly Hills, California 90211
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.